(Q39016180)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Magdalena Malm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Vladimir Tolmachev

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

John Löfblom

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

10

Stefan Ståhl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Maria Rosestedt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Zohreh Varasteh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ken Andersson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ram Kumar Selvaraju

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Mohamed Altai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Hadis Honarvar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Joanna Strand

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

13 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1450-1459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-014-2733-7

10 March 2020

exact match

0 references

cites work

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Signal transduction and oncogenesis by ErbB/HER receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Targeting HER receptors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

The promise of anti-ErbB3 monoclonals as new cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Mechanisms of resistance to HER family targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

HER3 overexpression and survival in solid tumors: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Immuno-PET: a navigator in monoclonal antibody development and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Bacterial display in combinatorial protein engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Imaging of HER-2 overexpression in tumors for guiding therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2733-7

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

21 January 2018

1 reference

12 December 2020

Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?

1 reference

12 December 2020

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors

1 reference

12 December 2020

Kahalalide F induces necrosis-like cell death that involves depletion of ErbB3 and inhibition of Akt signaling.

1 reference

12 December 2020

Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex

1 reference

12 December 2020

10.1007/S00259-014-2733-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622956%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference